seasonal quadrivalent influenza vaccine
Showing 26 - 50 of 9,537
Seasonal Influenza Trial in United States (mRNA-1010, Placebo, Active Comparator)
Recruiting
- Seasonal Influenza
- mRNA-1010
- +2 more
-
Phoenix, Arizona
- +20 more
Apr 7, 2022
Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)
Not yet recruiting
- Influenza, Human
- aQIV
- QIV
-
Batumi, Georgia
- +16 more
Oct 11, 2023
Influenza Trial in Panama (CVSQIV)
Recruiting
- Influenza
- CVSQIV
-
Panama, Calidonia, Panama City, Panama
- +2 more
Mar 10, 2022
Seasonal Influenza Trial in Argentina, Australia, Colombia (mRNA-1010, Licensed quadrivalent inactivated seasonal influenza
Active, not recruiting
- Seasonal Influenza
- mRNA-1010
- Licensed quadrivalent inactivated seasonal influenza vaccine
-
Buenos Aires, Argentina
- +52 more
Sep 19, 2022
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults
Recruiting
- Influenza
- +2 more
- Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
- High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
-
Oakland, CaliforniaKaiser Permanente Northern California (entire region)
Sep 1, 2023
Flucelvax (TIVc or QIVc) Pregnancy Registry
Completed
- Influenza, Human
- +2 more
- Flucelvax Trivalent Influenza Vaccine
- Flucelvax Quadrivalent Influenza Vaccine
-
Wilmington, North CarolinaSyneos Health
Mar 17, 2021
Vaccination; Infection Trial (Vaccine injection)
Not yet recruiting
- Vaccination; Infection
- Vaccine injection
- (no location specified)
Oct 12, 2023
Respiratory Syncytial Virus Trial in United States (Placebo, mRNA-1345, Fluzone HD)
Not yet recruiting
- Respiratory Syncytial Virus
- Placebo
- +2 more
-
Scottsdale, Arizona
- +32 more
Sep 23, 2023
Influenza Trial in Santiago de Compostela (Influenza vaccine)
Recruiting
- Influenza
- Influenza vaccine
-
Santiago de Compostela, A Coruña, SpainGeneral Public Health Directorate of Galician Health Service
Nov 15, 2023
Influenza, Vaccines Trial in Chile (Tetravalent influenza vaccine developed by Sinovac Biotech Co.)
Recruiting
- Influenza
- Vaccines
- Tetravalent influenza vaccine developed by Sinovac Biotech Co.
-
Puerto Montt, Los Lagos, Chile
- +4 more
Aug 7, 2022
Influenza Trial in Raymond Terrace (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Brand 1), Quadrivalent Inactivated
Not yet recruiting
- Influenza
- OVX836 480µg
- +3 more
-
Raymond Terrace, Brisbane, AustraliaMater Misericordiae University Hospital
Feb 9, 2023
Influenza, Human Trial (Quadrivalent Influenza Vaccine (split virion, inactivated), Trivalent Influenza Vaccine (split virion,
Not yet recruiting
- Influenza, Human
- Quadrivalent Influenza Vaccine (split virion, inactivated)
- +2 more
- (no location specified)
Mar 9, 2023
Influenza Trial in Taizhou (Quadrivalent influenza virus subunit vaccine, Quadrivalent split influenza virus vaccine)
Not yet recruiting
- Influenza
- Quadrivalent influenza virus subunit vaccine
- Quadrivalent split influenza virus vaccine
-
Taizhou, Jiangsu, ChinaAb&b Biotechnology Co., Ltd.JS
Jan 12, 2023
Influenza Trial in Brookvale (OVX836 480µg, Quadrivalent Inactivated Influenza Vaccine (Fluarix® Tetra), Placebo)
Completed
- Influenza
- OVX836 480µg
- +2 more
-
Brookvale, New South Wales, AustraliaNorthern Beaches Clinical Research
Dec 15, 2022
Vaccine Reaction Trial in New Haven (MicronJet, Fluzone® Quadrivalent)
Not yet recruiting
- Vaccine Reaction
- MicronJet
- Fluzone® Quadrivalent
-
New Haven, ConnecticutChurch Street Research Unit
Sep 27, 2023
Influenza Immunization Trial (Recombinant influenza vaccine (RIV4) season/2022-2023/NH, Quadrivalent influenza vaccine (IIV4)
Not yet recruiting
- Influenza Immunization
- Recombinant influenza vaccine (RIV4) season/2022-2023/NH
- Quadrivalent influenza vaccine (IIV4) season/2022-2023/NH
- (no location specified)
Aug 23, 2022
VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During
Not yet recruiting
- Influenza Immunization (Healthy Volunteers)
- Quadrivalent Influenza Vaccine
- High-Dose Quadrivalent Influenza Vaccine
- (no location specified)
Sep 22, 2023
Prevention of Influenza Trial in Changsha (Investigational Vaccine(0.25ml/vial), Investigational Vaccine(0.5ml/vial), Active
Not yet recruiting
- Prevention of Influenza
- Investigational Vaccine(0.25ml/vial)
- +2 more
-
Changsha, Hunan, ChinaHunan Provincial Center for Disease Control and Prevention
Dec 6, 2022
Influenza Trial in Lima (FLUAD Quadrivalent, FluQuadri)
Active, not recruiting
- Influenza
- FLUAD Quadrivalent
- FluQuadri
-
Lima, Peru
- +1 more
Sep 19, 2023
Influenza, Influenza Immunisation Trial in Iowa City, Cincinnati, Houston (Influenza Multimeric-001 Vaccine, Placebo,
Completed
- Influenza
- Influenza Immunisation
- Influenza Multimeric-001 Vaccine
- +2 more
-
Iowa City, Iowa
- +2 more
Jun 2, 2020
Immunization; Infection, Transplantation Infection, Influenza Trial in Nashville (Standard Dose Quadrivalent Inactivated
Not yet recruiting
- Immunization; Infection
- +2 more
- Standard Dose Quadrivalent Inactivated Influenza Vaccine
- High Dose Quadrivalent Inactivated Influenza Vaccine
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 11, 2023
Influenza Trial in Lianyungang (Quadrivalent influenza vaccine)
Completed
- Influenza
- Quadrivalent influenza vaccine
-
Lianyungang, Jiangsu, ChinaDonghai County Center for Disease Control and Prevention
Aug 13, 2022
Seasonal Influenza Trial in United States (mRNA-1011.1, mRNA-1011.2, mRNA-1012.1)
Recruiting
- Seasonal Influenza
- mRNA-1011.1
- +5 more
-
Lakewood, California
- +21 more
Apr 12, 2023
Influenza, Hepatitis A, Typhoid Trial in Stanford (Fluzone® quadrivalent, Fluzone High Dose, Fluad)
Active, not recruiting
- Influenza
- +3 more
- Fluzone® quadrivalent
- +5 more
-
Stanford, CaliforniaStanford LPCH Vaccine Program
Dec 12, 2022
Influenza and Pneumonia Trial in Taizhou (Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal
Completed
- Influenza and Pneumonia
- Combined vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
- Separate vaccination with quadrivalent influenza vaccine and 23-valent pneumococcal polysaccharide vaccine
-
Taizhou, Jiangsu, China
- +3 more
Jul 20, 2022